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Prevalence of congenital microcephaly and
its risk factors in an area at risk of Zika
outbreaks
Songying Shen1,2†, Wanqing Xiao1,2†, Lifang Zhang1,2†, Jinhua Lu1,2, Anna Funk3,4, Jianrong He1,2, Si Tu1,2, Jia Yu2,
Li Yang2, Arnaud Fontanet4, Wei Bao5, Kar Keung Cheng6 and Xiu Qiu1,2,7*
Abstract
Background: Prevalence of neonatal microcephaly in populations without Zika-epidemics is sparse. The study
aimed to report baseline prevalence of congenital microcephaly and its relationship with prenatal factors in an area
at risk of Zika outbreak.
Methods: This study included singletons born after 24 gestational weeks in 2017–2018 at four hospitals in
Guangzhou, China. Microcephaly was defined as a head circumference at birth >3SD below the mean for sex and
gestational age. Prevalence of microcephaly was estimated by binomial exact method. Multivariable logistic
regression was used to examine the associations of microcephaly with prenatal factors. The population attributable
fraction (PAF) for associated risk factors was calculated.
Results: Of 46,610 live births included, 154 (3.3, 95% CI 2.8–3.9 per 1000 live births) microcephalies were identified.
Maternal hepatitis B virus carriers (HBV, OR 1.80, 95% CI 1.05–3.10) and primipara (OR 2.68, 95% CI 1.89–3.81) had
higher risk of having a microcephalic baby. Higher prevalence of microcephaly was observed in women who had
premature labor (OR 1.98, 95% CI 1.17–3.34) and had a baby with fetal growth restriction (OR 16.38, 95% CI 11.81–
22.71). Four identified factors (HBV, primiparity, preterm labor, and fetal growth restriction) contributed to 66.4% of
the risk of microcephaly.
Conclusions: The prevalence of microcephaly in Guangzhou was higher than expected. This study identified four
prenatal risk factors that, together, contributed to two-thirds of the increased risk of microcephaly. This is the first
reported association between maternal HBV carrier status and microcephaly.
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Background
Congenital microcephaly is characterized as a smaller
head compared to others of the same sex and gestational
age. Infants with microcephaly have a significantly in-
creased risk of developmental delay, intellectual disabil-
ity, long-term disability, and even mortality [1–5]. The
World Health Organization (WHO) recommends that
early intervention with multidisciplinary approaches
should be used to promote the neurodevelopment of ba-
bies with microcephaly [6]. Early intervention in infants
with neurodevelopmental disorders that focus on redu-
cing problems and maximizing a child’s abilities can help
improve the children’s quality of life [7]. An understand-
ing of the maternal and neonatal factors related to
microcephaly at birth is likely to facilitate early identifi-
cation of microcephaly and thus effective intervention.
Relatively well-known causes of microcephaly include
maternal infections, such as Zika virus and cytomegalo-
virus, genetic factors, and teratogens. These understand-
ings are mainly based on evidence from recent Zika-
epidemic areas [8–10]. The epidemiology of microceph-
aly in populations without an outbreak of Zika virus in-
fection is poorly described. In addition, congenital
microcephaly can be subdivided according to the pro-
portionality related to the overall anthropometry [11,
12]. Proportionate congenital microcephaly might result
from an intrauterine dystrophy [11] that impacts both
head and body growth, whereas disproportionate micro-
cephaly presents head growth lagged behind somatic
growth or weight gain [12]. Case series of pregnant
women with ZIKV infections have reported a dispropor-
tionate fetal growth profile [13–15], especially in those
infected in early stage of pregnancy [13], the mechanism
of which has been revealed by a recent animal study
[16]. The proportionality of head to body size is also
proposed to improve the classification and prognosis of
microcephaly in clinic [11, 17, 18]. In spite of the evi-
dence above, the epidemiology of different subtypes of
microcephaly remains largely unknown.
Guangzhou, located in South China, is an area with
frequent epidemics of dengue virus, which is a flavivirus
of the same genus as Zika. It is possible that maternal
immunity to dengue virus promotes Zika infection and
Zika virus–induced microcephaly in fetuses [16]. Its nat-
ural environment is also facilitative for Zika trans-
mission. Meanwhile, as a cosmopolitan city and an
important hub port city of “the Belt and Road” in South
China, Guangzhou shares frequent communications with
countries where Zika virus is circulating, which may also
facilitate the transmission of the disease. Evidence from
Americas [19, 20] and a recent study from Angola [21]
showed that prolonged local transmission of Zika virus
may have existed before the detection of the outbreak,
highlighting the challenge for potential risk of Zika
transmission faced by South China. Improved under-
standing of the baseline epidemiology of microcephaly in
such areas is essential to evaluate the true severity of an
eventual outbreak. Using the data from a large cross-
sectional study in Guangzhou, China, we aimed to esti-
mate the prevalence of, and perinatal factors related to
congenital microcephaly and its subtypes.
Methods
Study design, setting and population
As head circumference (HC) measurement is not rou-
tinely collected and recorded in clinical practice in
China, a surveillance study for HC at birth was intro-
duced in February 2017 in four hospitals in Guangzhou,
China. The four hospitals were selected using a cluster
sampling from 13 municipal and district-level Maternal
and Child Care Service Centers in Guangzhou, including
two municipal tertiary healthcare centers (two campuses
of Guangzhou Women and Children’s Medical Center),
one district-level tertiary centers (Huadu Maternal and
Child Care Service Center) and one district-level second-
ary centers (Liwan Maternal and Child Care Service
Center), located in the central, north and west areas of
Guangzhou, China, respectively [22]. GWCMC provides
services to pregnancies from all 11 districts of the city.
Huadu and Liwan Maternal and Child Care Service Cen-
ter mainly provide services to pregnancies from Huadu
and Liwan district, respectively. The number of live
births in these four study hospitals accounted for 14.1%
of total live births in Guangzhou city during the study
period. Singletons born at 24–42 gestational weeks be-
tween February 10th, 2017 and May 31st, 2018 were in-
cluded. Stillbirths and those with a brain and central
nervous system (CNS) abnormality (ICD-10 code: O35.0,
Q00-Q07 excluding Q02), and/or chromosome abnor-
mality (ICD-10 code: O351, Q90-Q99), with unknown
sex, or with missing or implausible data on HC were ex-
cluded. The study protocol was approved by the
Guangzhou Women and Children’s Medical Center Eth-
ics Approval Board (No. 2016111865–2).
HC measurements and definition of microcephaly
The HC of the newborns was measured at each study
center by a uniform instrument, namely the Seca HC
measuring band 212, made of non-stretching Teflon.
The midwives were trained to follow a standard protocol
before the study was started. The definition of HC is the
widest possible circumference of the head around the
back of the head with the measuring band held above
eyebrow and ears. The HC measurements of the new-
borns were completed immediately after birth. All mea-
surements were read to the nearest millimeter and then
recorded. Each newborn was measured twice and the
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average value was recorded. The maximum difference
accepted between the two measurements was 4 mm.
The Z-scores of HC at birth was calculated according
to INTERGROWTH-21st newborn size standards by
gestational age and sex [23]. Microcephaly was defined
as an HC Z-score at birth < − 3.0 [6, 11, 24]. According
to the HC-to-birth weight proportionality, microcephaly
was grouped into two subtypes: disproportionate micro-
cephaly, defined as the difference between HC Z-score
and birth weight Z-score (namely HC Z-score minus
birth weight Z-score) < − 3.0, which represents a head
growth being lagged behind body growth by 3 Z-score
when refering to the standard population; proportionate
microcephaly, defined as the difference between HC Z-
score and birth weight Z-score ≥ − 3.0.
Data abstraction
Data on maternal age, parity, gestational diabetes melli-
tus (GDM), hypertensive disorders of pregnancy (HDP),
birth weight, gestational age at delivery, and newborn
sex were obtained from the Guangzhou Perinatal Health
Care and Delivery Surveillance System, which covers
more than 99% of deliveries in Guangzhou [25]. GDM
diagnosis was based on the International Association of
Diabetes and Pregnancy Study Groups criteria (IADPSG
criteria, FPG ≥ 5.1 mmol/l, 1 h glucose≥10.0 mmol/l, and
2 h glucose≥8.5 mmol/l) [26]. HDP included pre-existing
hypertension with or without superimposed proteinuria,
gestational hypertension without significant proteinuria,
preeclampsia, and eclampsia [27]. All pregnant women
were screened for serum HBsAg at their first antenatal
visit in GWCMC using enzyme-linked immunosorbent
assay (ELISA) kits (Shanghai Kehua bio-engineering Co.,
Ltd., China). Maternal carrier of hepatitis B virus (HBV)
was defined as positive HBs Ag. All neonates of mothers
with positive HBs Ag received hepatitis B vaccine and
hepatitis B immune globulin immediately after birth and
hepatitis B vaccine at 1 month and 6months of age. Be-
cause an electronic medical record system is only estab-
lished in GWCMC, data on maternal carriers of HBV
(ICD-10 code: Z22.5) and maternal hepatitis B were only
available and obtained from the electronic medical re-
cords in two GWCMC campuses through linkage to the
hospital information system with a unique identifier.
Birth weight was measured by midwives immediately
after delivery. Birth weight Z-scores were calculated ac-
cording to INTERGROWTH-21st newborn size stan-
dards by gestational age and sex [23]. Gestational age
was estimated from ultrasound examination during the
first or second trimester. Fetal growth restriction (FGR)
was defined as a birth weight lower than the 10th per-
centile for gestational age by sex. Preterm labor was de-
fined as labor before 37 weeks of gestation.
Statistical analysis
Robust regression with the iteratively reweighted least
square procedure was used to identify implausible HC
values either caused by misclassification of gestational
age or by invalid HC measurements. HC values with re-
sidual out of range of − 3.89 SD and + 3.89 SD were con-
sidered as outliers [28, 29].
The prevalence of microcephaly and its subtypes was
estimated and the 95% CI was calculated using the bino-
mial exact method. Data were summarized as means
(standard deviations) for continuous variables and fre-
quency (percentage) for categorical variables.
Multivariable logistic regression models were applied
to estimate the unadjusted and adjusted odds ratios
(ORs) and 95% confidence intervals (CIs) for the associ-
ation between prenatal characteristics and the risk of
microcephaly or microcephaly subtypes, with non-
microcephaly (HC Z-score at birth ≥ − 3.0) as the refer-
ence. In models for the associations with maternal age,
GDM, HDP, and parity, these characteristics entered the
model simultaneously and were mutually adjusted for
each other. The association with maternal carrier of
HBV was assessed among births in GWCMC, adjusted
for maternal age at conception, parity, HDP, GDM, year
of birth, and place of birth. Based on the year when rou-
tine hepatitis B immunization for newborns was imple-
mented, the year of birth was grouped into a binary
variable (“before 1992” and “in 1992 or after”) [30, 31].
Maternal place of birth was classified into two regions
according the distribution of HBV infection, including
the eastern region (including Beijing, Fujian, Guangdong,
Jiangsu, Liaoning, Shandong, Shanghai, Tianjin, and
Zhejiang) and the central/western region (including An-
hui, Hainan, Hebei, Heilongjiang, Henan, Hubei, Hunan,
Jiangxi, Jilin, Shanxi, Chongqing, Gansu, Guangxi, Gui-
zhou, Inner Mongolia, Ningxia, Qinghai, Shaanxi, Si-
chuan, Tibet, Yunnan, and Xinjiang) [32]. In the models
to examine the association of microcephaly with preterm
labor and FGR, maternal age, parity, HDP, GDM, and
infant’s sex were adjusted for. We calculated the popula-
tion attributable fraction (PAF) and its 95% confidence
interval associated with identified factors for the risk of
microcephaly and its subtypes in the study population,
using a published %PAR SAS macro [33].
All analyses were done with SAS version 9.3 (SAS
Institute, Cary, NC, USA). P < 0.05 was considered
significant.
Results
A total of 47,369 singletons were eligible, with 17,798
births from Zhujiang Newtown Campus of GWCMC,
12,270 births from Maternal-Infant Campus of GWCM
C, 13,217 from Guangzhou Huadu Maternal and Child
Care Service Center, and 4084 from Guangzhou Liwan
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Maternal and Child Care Service Center. After excluding
newborns with unknown sex (n = 3) and missing (n =
328) or implausible HC data (n = 145), stillbirths (n =
222), and those with brain and central nervous system
(CNS) abnormalities (n = 25) and/or chromosome ab-
normalities (n = 36), 46,610 newborns were included in
the final analysis.
There were 154 newborns identified with microceph-
aly across all births, with a prevalence of 3.3 (95% CI,
2.8–3.9 per 1000 live births). Of these, 14 were dispro-
portionate, with a prevalence of 0.3 (95% CI, 0.2–0.5 per
1000 live births), and the remaining 140 were propor-
tionate, with a prevalence of 3 (95% CI, 2.5–3.5 per 1000
live births).
Table 1 shows the characteristics of the study popula-
tion. There were 83.7% (39, 019/46,610) of mothers who
were less than 35 years of age. The proportion of
mothers who were primiparous was 41.9% (19,534/46,
610). There were 3.2% (1493/46,610) and 14.6% (6787/
46,610) of mothers diagnosed with HDP and GDM, re-
spectively. A total of 7.5% (2189/29,187) of mothers were
carriers of HBV, of whom only 9 were diagnosed with
hepatitis B. The proportions of preterm labor and FGR
were 5.6 and 7.0%, respectively. Male accounted for
53.5% (n = 24,927) of the newborns. The mean HC Z
score, birth weight Z score and difference between the
HC Z-score and birth weight Z-score were − 0.3 (SD
1.0), 0.0 (SD 0.9), and 0.3 (0.8), respectively.
Associations between prenatal factors and microcephaly
are shown in Fig. 1. Being a maternal carrier of HBV (ad-
justed OR 1.80; 95% CI, 1.05–3.10) and primiparity (adjusted
OR 2.68; 95% CI, 1.89–3.81) were significantly associated
with microcephaly. There was no association of microceph-
aly with maternal age, GDM, or HDP. Higher microcephaly
risk was associated with preterm birth (OR 1.98; 95% CI,
1.17–3.34), SGA (OR 16.38; 95% CI, 11.81–22.71).
Associations between prenatal factors and microceph-
aly subtypes are shown in Table 2. Newborns had a
higher risk of proportionate microcephaly if they were
SGA (adjusted OR 20.76, 95% CI 14.61–29.51) or if their
mothers were primiparous (adjusted OR 2.83, 95% CI
1.95–4.10) or had HDP (adjusted OR 2.06, 95% CI 1.04–
4.07). Newborns who were born preterm (adjusted OR
14.24, 95% CI 4.91–41.30) had a higher risk of dispro-
portionate microcephaly. Maternal HBV carrier status
was not significantly associated with either proportionate
(adjusted OR 1.73 95% CI 0.97–3.09) or disproportionate
(adjusted OR 2.51, 95% CI 0.55–11.53) microcephaly.
The PAF associated with identified risk factors for
microcephaly and its subtypes are presented in Table 3.
Table 1 Characteristics of 46,610 mother-child dyads
Characteristics Mean (SD) n (%)
Maternal age 30.2 (4.7)
< 35 years old 39,019 (83.7)
Primiparous 19,534 (41.9)
Hypertensive disorders of pregnancy 1493 (3.2)
Gestational diabetes 6787 (14.6)
Maternal carrier of HBVa 2189 (7.5)
Sex of newborns (Male) 24,927 (53.5)
Gestational age at birth, weeks 39.0 (1.5)
Preterm birth 2590 (5.6)
Birth weight of newborns, kg 3.2 (0.4)
Birth weight for gestational age of newborns, Z-scoreb 0.0 (0.9)
Small for gestational agec 3265 (7.0)
Head circumference of newborns, cm 33.3 (1.3)
Head circumference of newborns, Z-scoreb −0.3 (1.0)
< −3.0 154 (0.3)
≥ −3.0 & < −2.0 1777 (3.8)
BWHC Z-score differenced −0.3 (0.8)
< −3.0 58 (0.1)
≥ −3.0 & < −2.0 987 (2.1)
HBV Hepatitis B Virus, SD Standard deviation, BWHC Birth weight and head circumference of newborns
aAnalyzed among the births born in two campuses of Guangzhou Women and Children’s Medical Center (n = 29,493)
bCalculated according to the INTERGROWTH-21st standards
cDefined as gestational age and sex-adjusted birth weight < 10th percentile based on the INTERGROWTH-21st newborn size standard
dDefined as the difference between head circumference Z-score and birth weight Z-score of newborns
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In the study population, 66.4% (95% CI 43.9–81.1%) of
the risk of microcephaly could be attributed to the four
associated risk factors, including primiparity, maternal
HBV carriage status, SGA, and preterm birth. The most
important factors were SGA and primiparity, with PAF
being 50.6% (95% CI 38.8–60.8%) and 28.9% (95% CI
10.3–45.5%), respectively. For disproportionate micro-
cephaly, the PAF associated with preterm birth was
47.5% (95% CI 13.1–71.7%). For proportionate micro-
cephaly, 56.5, 28.2, and 1.9% of the risk could be attrib-
uted to SGA, primiparity, and HDP, respectively,
constituting a combined PAF of 67.7% (95% CI 47.7–
81.1%).
Discussion
This multi-center study found that the prevalence of
microcephaly was 0.33%, which is higher than the ex-
pected risk of 0.13% in a population with normally dis-
tributed HC and using a definition of HC Z score
smaller than − 3. Microcephaly was associated with ma-
ternal HBV carrier status, primiparity, FGR, and preterm
birth, which together contributed to two-thirds of the
risk of microcephaly. The risk factors associated with
microcephaly varied between proportionate and dispro-
portionate microcephaly.
Although the estimated prevalence of microcephaly in
the present study is lower than pre-Zika virus epidemic
estimate in two cities in Brazil (5 ~ 7 per 1000 births),
where the diagnosis of microcephaly was also based on
the INTERGROWTH-21st standard [34], it was ~ 2 folds
higher than the expected rate (1.3 per 1000 births). The
rate is also much higher than that from birth defect sur-
veillance systems in other regions of the world, which
were reported as 0.20 per 1000 births in Europe, 0.23
per 1000 births in India, 0.44 per 10 00 births in South
America pre-Zika, and around 0.87 per 1000 live births
before the Zika virus epidemic in the US [17, 35–37].
The variation in the definition of microcephaly used is
likely to contribute largely to the variation in the re-
ported prevalence across the studies mentioned. Never-
theless, this study showed that microcephaly is sub-
endemic in a region without ongoing Zika virus
transmission.
Considering that early neurodevelopmental interven-
tions recommended by the World Health Organization
could improve microcephalic children’s quality of life
[6], identification of risk factors and comorbidities for
microcephaly and its subtypes may allow for timely diag-
noses and enable clinical practitioners to provide appro-
priate counseling about the long-term prognosis. The
present study adds to the evidence that risk factors
Fig. 1 Pernatal factors associated with microcephaly. OR, odds ratio; HDP, hypertensive disorders of pregnancy; GDM, Gestational diabetes
mellitus; HBV, Hepatitis B Virus. aNon-microcephaly (head circumference Z-score≥ − 3.0) as the reference group. bIn models for the associations
with maternal age, GDM, HDP, and parity, these characteristics entered the model simultaneously and were mutually adjusted for each other.
cAnalyzed only among all births born in two campuses of Guangzhou Women and Children’s Medical Center. dAdjusted for maternal age,
hypertensive disorders of pregnancy, and gestational diabetes mellitus and parity, year of birth, and place of birth. eAdjusted for maternal age,
hypertensive disorders of pregnancy, and gestational diabetes mellitus, parity and sex of newborn.
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associated with microcephaly varied between two sub-
types, proportionate and disproportionate, of
microcephaly.
In the present study, we found that infants with pro-
portionate microcephaly included more infants with
SGA, 18–22% of whom were reported constitutionally
small but healthy in the previous studies [38]. As the
definition of microcephaly was only based on head cir-
cumference rather than aetiological investigations, it is
inevitable that infants with proportionate microcephaly
include some SGA infants whose head sizes are small
but without structural brain lesion [39].
Table 2 Perinatal factors associated with microcephaly phenotypes
Perinatal
factors
Disproportionate microcephaly Proportionate microcephaly
n (%) Adjusted OR (95% CI)a n (%) Adjusted OR (95% CI)a
Maternal ageb
< 35 years old 13 (0.03) 1.90 (0.23–15.42) 131 (0.34) 1.91 (0.95–3.85)
≥ 35 years old 1 (0.01) Ref 9 (0.12) Ref
Parityb
Primiparity 8 (0.04) 1.64 (0.55–4.87) 97 (0.50) 2.83 (1.95–4.10)
Multiparity 6 (0.02) Ref 43 (0.16) Ref
HDPb
Yes 0 (0.00) – 9 (0.60) 2.06 (1.04–4.07)
No 14 (0.03) – 131 (0.29) Ref
GDMb
Yes 1 (0.01) 0.52 (0.07–4.04) 21 (0.31) 1.18 (0.74–1.89)
No 13 (0.03) Ref 119 (0.30) Ref
Maternal carrier of HBVc, d
Yes 2 (0.09) 2.51 (0.55–11.53) 13 (0.59) 1.73 (0.97–3.09)
No 10 (0.04) Ref 104 (0.39) Ref
Preterm birthe
Yes 6 (0.23) 14.24 (4.91–41.30) 10 (0.39) 1.29 (0.68–2.47)
No 8 (0.02) Ref 130 (0.30) Ref
Small for gestational agee
Yes 0 (0.00) – 89 (2.73) 20.76 (14.61–29.51)
No 14 (0.03) – 51 (0.12) Ref
OR Odds ratio, CI Confidence interval, HDP Hypertensive disorders of pregnancy, GDM Gestational diabetes mellitus, HBV Hepatitis B Virus
aNon-microcephaly (head circumference Z-score ≥ −3.0) as the reference group
bIn models for the associations with maternal age, GDM, HDP, and parity, these characteristics entered the model simultaneously and were mutually adjusted for
each other
cAnalyzed only among all births born in two campuses of Guangzhou Women and Children’s Medical Center
dAdjusted for maternal age, hypertensive disorders of pregnancy, and gestational diabetes mellitus and parity, year of birth, and place of birth
eAdjusted for maternal age, hypertensive disorders of pregnancy, gestational diabetes mellitus, and parity, sex of newborn
Table 3 Population attributable fractions and 95% confidence interval associated with identified factors for microcephaly and its
subtypes
Risk factors Microcephaly Disproportionate microcephaly Proportionate microcephaly
All risk factors combined 66.4% (43.9–81.1%) 47.5% (13.1–71.7%) 67.7% (47.7–81.1%)
Specific factors
Primiparity 28.9% (10.3–45.5%) – 28.2% (7.9–46.3%)
HDP – – 1.9% (− 3.2 to 6.9%)
Maternal carrier of HBV 4.8% (−1.2 to 10.8%) – –
Small for gestational age 50.6% (38.8–60.8%) – 56.5% (44.0–66.9%)
Preterm birth 4.0% (− 1.4 to 9.4%) 47.5% (13.1–71.7%) –
HDP Hypertensive disorders of pregnancy, HBV Hepatitis B Virus
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The definition of disproportionate microcephaly in the
present study represents a head growth being signifi-
cantly lagged behind body growth. Previous studies de-
fined disproportionate microcephaly as HC Z-score < − 3
and weight or height Z-score ≥ − 3, which will include a
large portion of infants whose head growth being little
lagged behind body growth [12, 34]. It is intriguing to
find that disproportionate microcephaly is associated
with preterm labor, especially as preterm labor has itself
been linked to neurodevelopmental delays [40–43]. On
one hand, the finding may suggest that factors contribut-
ing to preterm labor might also have an impact on those
related to the pathogenesis of microcephaly, such as
neural progenitor cell proliferation, differentiation, and
apoptosis [8]. Further studies are warranted for identify-
ing these factors. On the other hand, the disruption of
the normal intrauterine neurodevelopment, a critical
period for brain growth and maturation, would further
exacerbate the neurodevelopmental disorders of the chil-
dren [40, 43]. Thus, disproportionate microcephaly may
have a greater chance of representing ‘true’ microceph-
aly. Identification of disproportionate microcephaly in
preterm babies and referring them to early intervention
services to improve neurodevelopmental outcomes
would be urgently needed.
This study is the first to report the association between
maternal HBV carrier status and a higher risk of micro-
cephaly. Previous studies regarding maternal virus infec-
tion and microcephaly focused mainly on the Zika virus
and were conducted mainly in Zika-epidemic areas.
Some previous studies have found that Hepatitis B sur-
face antigen (HBsAg) positivity during pregnancy in-
creased the risk of congenital malformation [44].
However, few studies have investigated the influence of
maternal HBsAg positivity on fetal brain growth. As
TORCH (Toxoplasma gondii, other microorganisms, ru-
bella virus, cytomegalovirus, and herpes simplex virus)
infections are one of the main causes of microcephaly,
future studies are needed to confirm this association and
determine the public health impact of maternal HBV in-
fection on the risk of microcephaly in regions with high
HBV infection burden, such as in China and Africa [45].
Major strengths of this study include the large sample
size, which allows for the identification of novel risk fac-
tors of conditions with low prevalence, and the high-
quality of HC data that was ensured by standardized
measurements. Importantly, using high quality data we
provide approximate population-based baseline preva-
lence estimations for future surveillance, which will be-
come very important in the case of outbreaks of Zika or
other infectious diseases in this region of China. This
study has some limitations. First, we only collected the
data in one developed city in China, which limits its
generalization to other regions. However, Guangzhou is
a megalopolis with a large migrating population moving
in from other areas of China. Second, the association be-
tween HBV and microcephaly should be interpreted
with caution because potential unrecognized con-
founders within populations with higher hepatitis B rates
may drive this association. However, in a subgroup of
pregnant women who participated in both the current
study and the Born in Guangzhou Cohort Study [46],
the ORs changed very little after additional adjustment
for known influential factors, such as alcohol consump-
tion, smoking, and use of emergency contraceptives dur-
ing early pregnancy (data not shown). This suggests that
the observed associations are unlikely to be largely chan-
ged by adjustment for known confounders. Third, the
power to detect the associations between risk factors
and disproportionate microcephaly might be limited due
to the small sample size of this subgroup. Finally, only
microcephaly-status and comorbidities at birth were ob-
served. Long-term neurodevelopmental and other out-
comes of infants with microcephaly, according to
subtype, at birth should be further evaluated in future
studies in order to better understand the clinical signifi-
cance of finding microcephaly without other brain ab-
normalities at birth.
Conclusions
In summary, based on this multi-center study in an area
not yet experiencing, but at risk of, Zika outbreaks, the
estimated prevalence of microcephaly was higher than
expected. Four factors, namely maternal HBV carrier
status, primiparity, SGA, and preterm birth, are associ-
ated with 66.4% of the increased risk of microcephaly,
and the risk factors varied between different subtypes of
microcephaly. This study contributed to the better un-
derstanding of microcephaly subtypes characteristics. In
addition, as infection is a main cause of microcephaly,
the association between maternal HBV carrier status and
microcephaly, which was first reported in this study,
warrants further investigations.
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